Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders

被引：52

作者：

Dömötör A. ^{[1
]}

Peidl Z. ^{[1
]}

Vincze Á. ^{[1
]}

Hunyady B. ^{[1
]}

Szolcsányi J. ^{[2
]}

Kereskay L. ^{[3
]}

Szekeres G. ^{[3
]}

Mózsik G. ^{[1
]}

机构：

[1] First Department of Medicine, Medical and Health Centre, University of Pécs

[2] Department of Pharmacology and Pharmacotherapy, University of Pécs

[3] Department of Pathology, Medical and Health Centre, University of Pécs

来源：

InflammoPharmacology | 2005年 / 13卷 / 1-3期

关键词：

Calcitonin-gene-related peptide (CGRP); Capsaicin-sensitive afferent nerves; Gastrointestinal disorders; Human; Substance P; Transient receptor potential vanilloid 1 (TRPV1);

D O I：

10.1163/156856005774423737

中图分类号：

学科分类号：

摘要：

The immunohistochemical distribution of capsaicin/vanilloid (transient receptor potential vanilloid 1, TRPV1) receptors and neuropeptides (CGRP, SP) was studied in the gastrointestinal mucosal biopsies of patients with gastritis, erosions, ulcers, polyps, adenocarcinoma, chronic inflammatory bowel diseases, polyps without and with hyperplasia, dysplasia and adenocarcinoma in colon. The studies were carried out in 127 patients and 30 people with only functional dyspepsia (without any histological alteration). The results were: (1) the positivity of TRPV1 receptor and CGRP was detected, and weak participation of SP was detected in patients with different gastric diseases; (2) the presence of TRPV1, CGRP and SP could be detected in chronic inflammation of bowel disease; (3) SP could not detected in patients with colon polyps, dysplasia and adenocarcinoma; (4) the presence of TRPV1 and CGRP was proved in colon dysplasia and adenocarcinoma. We conclude that (1) the immunohistochemical distribution of TRPV1, CGRP and SP differs in gastrointestinal diseases of the upper and lower tract, and (2) the participation of TRPV1, CGRP and SP differs significantly in these different gastrointestinal diseases. © VSP 2005.

引用

页码：161 / 177

页数：16

共 17 条

[11]

Mozsik G., Par A., Par G., Et al., Insight into the molecular pharmacology to drugs acting on the afferent and efferent fibres of vagal nerve in the gastric mucosal protection, Ulcer Research, Proceedings of the 11th International Conference, pp. 163-168, (2004)

[12]

Mozsik G., Belagyi J., Szolcsanyi J., Et al., Capsaicin-sensitive afferent nerves and gastric mucosal protection on human healthy subjects. A critical overview, Mediators in Gastrointestinal Protection and Repair, pp. 43-62, (2004)

[13]

Mozsik G., Racz I., Szolcsanyi J., Gastroprotection induced by capsaicin in human healthy subjects, World J. Gastroenterol, (2005)

[14]

Mozsik G., Peidl Z., Szolcsanyi J., Et al., Participation of vanilloid/capsaicin receptors, substance P and calcitonin gene-related peptide in the omeprazole and omeprazole-like-induced gastric protection, Inflammopharmacology, 13, pp. 95-115, (2005)

[15]

Mozsik G., Rumi G., Domotor A., Et al., Involvement of serum retinoids and activated protein C in patients with oesophageas, gastric, liver, pancreatic and colorectal cancers in Hungary, World J. Gastroenterol., (2005)

[16]

Szolcsanyi J., Forty years in capsaicin reasearch for sensory pharmacology and physiology, Neuropeptides, 38, pp. 377-384, (2004)

[17]

Vincze A., Szekeres G., Kiraly A., Et al., The immunohistochemical distribution of capsaicin receptor, CGRP and SP in the human gastric mucosa in patients with different gastric disorders, Ulcer Research, Proceedings of the 11th International Conference, pp. 149-153, (2004)

← 1 2 →